BRIEF published on 02/19/2025 at 19:15, 1 year 6 months ago Aspire Biopharma Begins Trading on Nasdaq Following Merger Nasdaq Listing Business Combination Public Offering Drug Delivery Technology Aspire Biopharma
BRIEF published on 02/19/2025 at 19:15, 1 year 6 months ago Aspire Biopharma commence à être cotée au Nasdaq après sa fusion Technologie D'administration De Médicaments Cotation Au Nasdaq Regroupement D’entreprises Offre Publique De Vente Aspire Biopharma
PRESS RELEASE published on 02/19/2025 at 19:10, 1 year 6 months ago Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq Aspire Biopharma and PowerUp Acquisition Corp. completed their business combination, enhancing access to capital and new product development. Shares to trade on Nasdaq as ASBP and ASBPW Nasdaq Business Combination Aspire Biopharma PowerUp Acquisition Corp. Drug Delivery Mechanism
Published on 09/12/2026 at 02:35, 11 hours 3 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 38 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 33 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 13 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 38 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 8 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 23 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 28 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 53 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 23 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
